Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study
Jianghao Chen(Zero to Three), Ling Wang(Xijing Hospital), Ting Wang(Jilin University), Dong Li(Tongji University), Qing Yao(Tianjin Meteorological Bureau), Jing Wang(Shandong University), Ming Yu(Children's Hospital of Philadelphia), Juliang Zhang(Xijing Hospital), Yi Huan(Fujian Medical University), Xiaodong Zhou(Wenzhou Medical University)
Cited by 36
Related Papers
M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer
|Cancer Research|2018|672
Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma
|Cell Metabolism|2018|420
Global burden of metabolic diseases, 1990–2021
|Metabolism|2024|294
Characteristics of carbonaceous aerosol in the region of Beijing, Tianjin, and Hebei, China
|Atmospheric Environment|2013|190